Skyler Vise
Senior Director, Patient Services
Expertise:
Skyler is Senior Director of Patient Services at EVERSANA. He presents a decade of experience in access and adherence, with deep prowess in Immunology and Dermatology.
Skyler has held various roles from Program Specialist to leadership positions, lending him expertise in program design, build and implementation, as well as program risk and health assessment and mitigation pertaining to all existing business.
Articles by Skyler Vise
Improving the Patient Experience with Digital Tools
EVERSANA’s Patient Services expert, Skyler Vise, Senior Director, Client & Delivery Excellence, EVERSANA, and Ida Goldstein, Senior Director, Trade, Distribution, and Patient Services, Mirum Pharmaceutical, presented at Access USA covering how digital tools can improve the patient experience and communication for rare and ultra-rare disease patients. Rare disease patients often face significant challenges such as difficulty in finding accurate information about their conditions, lack of access to appropriate treatment, and limited opportunities to connect with healthcare providers. These challenges can lead to a lack of trust between patients and healthcare providers (HCPs) and can result in patients feeling isolated and unsupported. Additionally, as digital tools become more prevalent in the […]
Patient Assistance for Gene Therapies
EVERSANA’s experts Kevin O’Meara and Skyler Vise recently took the stage at Access USA to discuss patient services solutions for patient assistance programs (PAPs) supporting cell and gene therapies. During the session, the experts explore how PAPs help support patients in accessing and affording treatment, especially for high-cost therapies like cell and gene therapies. The discussion also emphasizes the need for collaborative approaches to patient services and support, with a focus on improving patient outcomes and ensuring access to life-changing therapies. Despite being crucial to the patient outcome, PAPs encounter numerous complexities and challenges. The experts suggest that these programs need to overcome four major hurdles: Limited funding: Patient assistance […]